INVARIANT LLC for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to: P.L. 111-148, the Patient Protection and Affordable Care Act; P.L. 111-152, the Health Care and Education Reconciliation Act; H.R. 1628, the American Health Care Act of 2017 and the Better Care Reconciliation Act, including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions; the high-cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017; H.R. 4616, regarding a one-year delay of the Cadillac Tax; H.R. 4620, regarding relief from the Health Insurance Tax; substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically the Overdose Prevention and Patient Safety Act (OPPS Act); and H.R. 1625, the Consolidated Appropriations Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
Taxation/Internal Revenue Code TAX
Issues related to: P.L. 111-148, the Patient Protection and Affordable Care Act; P.L. 111-152, the Health Care and Education Reconciliation Act; H.R. 1628, the American Health Care Act of 2017 and the Better Care Reconciliation Act; the high-cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017; H.R. 4616, regarding a one-year delay of the Cadillac Tax; H.R. 4620, regarding relief from the Health Insurance Tax; Senate motion to concur in the House amendment to the Senate amendment to H.R.195, CR/CHIP, with further amendment (includes: CR funding until February 8, 2018; 6 year CHIP; ACA tax delays).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN BAILEY | — |
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
Medicare/Medicaid MMM
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. CMS-4182-P/CMS-4182-CN: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.